NCT00652171View on ClinicalTrials.gov

Efficacy and Safety of Antidepressant Augmentation With Lamotrigine

PHASE3CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Depression
Interventions
DRUG

Lamotrigine

Lamotrigine was added to the ongoing antidepressant. The doses were titrated to 200mg/day.

DIETARY_SUPPLEMENT

Amide

Capsule of amide were given to this group of patients. They continued the ongoing antidepressants.

All Listed Sponsors
lead

Institute of Social Security of the Civil Servants of Minas Gerais

OTHER_GOV

NCT00652171 - Efficacy and Safety of Antidepressant Augmentation With Lamotrigine | Biotech Hunter | Biotech Hunter